BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yazu H, Miyazaki D, Fujishima H. Experience With 0.1% Tacrolimus Eye Drop for Noninfectious, Non-necrotizing Anterior Scleritis. Eye Contact Lens 2021;47:185-90. [PMID: 32404650 DOI: 10.1097/ICL.0000000000000696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kabaalioğlu Güner M, Mehra A, Smith WM. Novel strategies for the diagnosis and treatment of scleritis. Expert Review of Ophthalmology 2021;16:431-48. [DOI: 10.1080/17469899.2021.1984881] [Reference Citation Analysis]
2 Yazu H, Fukagawa K, Shimizu E, Sato Y, Fujishima H. Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases. Allergy Asthma Clin Immunol 2021;17:11. [PMID: 33522964 DOI: 10.1186/s13223-021-00513-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]